Multicenter pahse II trial of neoadjuvant goserelin acetate and tamoxifen treatment for premenopausal ER-positive and HER2-negative breast cancers
Not Applicable
- Conditions
- Premenopausal breast cancer
- Registration Number
- JPRN-UMIN000006945
- Lead Sponsor
- Department of Breast and Endocrine Surgery, Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Another cancer diagnosed within 5 years 2. Pregnant or nursing women 3. Cases who physician judged improper to entry this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method